Skip to main content

Table 2 Univariate and Multivariate Models for Overall Survival in Patients with GBM in the Cancer Genome Atlas (TCGA) Cohorta

From: Clinical significance of FBXO17 gene expression in high-grade glioma

Overall Survival Univariate analysis Multivariate analysisd
HR (95%CI)c P Valuee HR (95%CI)c P Valuee
IDH1 mut + wt cases (n = 311)b
FBXO17 expression 1.47 (1.24–1.74) < 0.0001 1.29 (1.04 --1.59) 0.018
IDH1 status
 Wild-type (288) 1 [Reference]   1 [Reference]  
 Mutation (23) 0.38 (0.21–0.68) 0.001 0.62 (0.31 --1.25) 0.179
Sex
 Female (113) 1 [Reference]   1 [Reference]  
 Male (198) 1.11 (0.85–1.45) 0.451 1.18 (0.90 --1.55) 0.216
Age, years
 < 60 (164)f 1 [Reference]   1 [Reference]  
 ≥ 60 (147) 1.74 (1.34 -- 2.26) < 0.0001 1.56 (1.20 -- 2.03) 0.001
IDH1 wt cases alone (n = 288)
FBXO17 expression 1.33 (1.08–1.64) 0.007 1.26 (1.02 --1.56) 0.034
Sex     
 Female (106) 1 [Reference]   1 [Reference]  
 Male (182) 1.23 (0.94–1.62) 0.138 1.23 (0.94 --1.62) 0.139
Age, years
 < 60 (144) 1 [Reference]   1 [Reference]  
 ≥ 60 (144) 1.69 (1.29 -- 2.21) < 0.0001 1.59 (1.21 -- 2.09) 0.001
  1. aIncluded are data from the 311 TCGA GBM patients who had all the following data available such as FBXO17 gene expression, IDH1 mutation, gender, age, survival time, and vital status. The numbers in parentheses denote the numbers of patients in the specified subgroups
  2. bwt, wide-type; mut, mutant
  3. cHR, hazard ratio; CI, confidence interval
  4. dBased on a multivariate Cox proportional hazards model, including all variables in the table
  5. eWald’s test, P values
  6. fThe median age of the common set is 60 years